Title : Treatment of diffuse histiocytic and diffuse mixed non-Hodgkin lymphomas with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP).

Pub. Date : 1988

PMID : 3203011






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Treatment of diffuse histiocytic and diffuse mixed non-Hodgkin lymphomas with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP). Cyclophosphamide DNA damage inducible transcript 3 Homo sapiens
2 Treatment of diffuse histiocytic and diffuse mixed non-Hodgkin lymphomas with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP). Prednisone DNA damage inducible transcript 3 Homo sapiens
3 The 5-year survival rate for stage I & II patients treated by CHOP plus radiotherapy was 70% as compared to 55% for those treated by CHOP only; this difference was not statistically significant. Adenosine Monophosphate DNA damage inducible transcript 3 Homo sapiens